The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Pseudolymphoma

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Pseudolymphoma

 

High impact information on Pseudolymphoma

 

Chemical compound and disease context of Pseudolymphoma

 

Biological context of Pseudolymphoma

 

Anatomical context of Pseudolymphoma

 

Gene context of Pseudolymphoma

 

Analytical, diagnostic and therapeutic context of Pseudolymphoma

References

  1. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Yang, W.I., Zukerberg, L.R., Motokura, T., Arnold, A., Harris, N.L. Am. J. Pathol. (1994) [Pubmed]
  2. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. Dang, H., Geiser, A.G., Letterio, J.J., Nakabayashi, T., Kong, L., Fernandes, G., Talal, N. J. Immunol. (1995) [Pubmed]
  3. Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns. Abbondazo, S.L., Irey, N.S., Frizzera, G. Am. J. Surg. Pathol. (1995) [Pubmed]
  4. Sjögren's syndrome with acute renal failure caused by renal pseudolymphoma. Cacoub, P., Ginsburg, C., Tazi, Z., Beaufils, H., Charlotte, F., Davi, F., Carde, P., Godeau, P. Am. J. Kidney Dis. (1996) [Pubmed]
  5. Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine. Cogrel, O., Beylot-Barry, M., Vergier, B., Dubus, P., Doutre, M.S., Merlio, J.P., Beylot, C. Br. J. Dermatol. (2001) [Pubmed]
  6. Pseudolymphoma at site of clonidine patch. Shelley, W.B., Shelley, E.D. Lancet (1997) [Pubmed]
  7. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray. Oka, T., Yoshino, T., Hayashi, K., Ohara, N., Nakanishi, T., Yamaai, Y., Hiraki, A., Sogawa, C.A., Kondo, E., Teramoto, N., Takahashi, K., Tsuchiyama, J., Akagi, T. Am. J. Pathol. (2001) [Pubmed]
  8. Proteolytic activity of human non-Hodgkin's lymphomas. Kossakowska, A.E., Hinek, A., Edwards, D.R., Lim, M.S., Zhang, C.L., Breitman, D.R., Prusinkiewicz, C., Stabbler, A.L., Urbanski, L.S., Urbanski, S.J. Am. J. Pathol. (1998) [Pubmed]
  9. Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas. Hauschild, A., Sterry, W. Am. J. Pathol. (1989) [Pubmed]
  10. Pseudolymphoma of the lung in a patient with systemic lupus erythematosus. Yum, M.N., Ziegler, J.R., Walker, P.D., Ridolfo, A.S., Brashear, R.E. Am. J. Med. (1979) [Pubmed]
  11. Drug-induced pseudolymphoma secondary to lamotrigine. Pathak, P., McLachlan, R.S. Neurology (1998) [Pubmed]
  12. Phenytoin-induced pseudolymphoma: reevaluation using modern molecular biology techniques. Jeng, Y.M., Tien, H.F., Su, I.J. Epilepsia (1996) [Pubmed]
  13. Drug induced pseudolymphoma secondary to ethosuximide. Masruha, M.R., Marques, C.M., Vilanova, L.C., de Seixas Alves, M.T., Peres, M.F., Rodrigues, M.G. J. Neurol. Neurosurg. Psychiatr. (2005) [Pubmed]
  14. Treatment of cutaneous pseudolymphoma with hydroxychloroquine. Stoll, D.M. J. Am. Acad. Dermatol. (1983) [Pubmed]
  15. Generalized nodular cutaneous pseudolymphoma associated with phenytoin therapy. Use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin. Braddock, S.W., Harrington, D., Vose, J. J. Am. Acad. Dermatol. (1992) [Pubmed]
  16. CD30-positive T-cell-rich pseudolymphoma induced by gold acupuncture. Kim, K.J., Lee, M.W., Choi, J.H., Sung, K.J., Moon, K.C., Koh, J.K. Br. J. Dermatol. (2002) [Pubmed]
  17. Immunoglobulin gene analysis of cutaneous pseudolymphoma by polymerase chain reaction. Nakayama, F., Kurosu, K., Yumoto, N., Mikata, A. J. Dermatol. (1995) [Pubmed]
  18. Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Garbuglia, A.R., Iezzi, T., Capobianchi, M.R., Pignoloni, P., Pulsoni, A., Sourdis, J., Pescarmona, E., Vitolo, D., Mandelli, F. International journal of immunopathology and pharmacology. (2003) [Pubmed]
  19. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome. D'Incan, M., Souteyrand, P., Bignon, Y.J., Fonck, Y., Roger, H. Archives of dermatology. (1992) [Pubmed]
  20. Bone marrow involvement in phenytoin induced 'pseudolymphoma'. Singer, J., Schmid, C., Souhami, R., Isaacson, P.G. Clinical oncology (Royal College of Radiologists (Great Britain)) (1993) [Pubmed]
  21. The role of chemokines in Hodgkin's disease. Teruya-Feldstein, J., Tosato, G., Jaffe, E.S. Leuk. Lymphoma (2000) [Pubmed]
  22. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. Cerroni, L., Volkenandt, M., Rieger, E., Soyer, H.P., Kerl, H. J. Invest. Dermatol. (1994) [Pubmed]
  23. Cutaneous pseudolymphoma occurring during methotrexate therapy for rheumatoid arthritis. Flipo, R.M., Delaporte, E., Lecomte-Houcke, M. J. Rheumatol. (1997) [Pubmed]
  24. MY7 monoclonal antibody for diagnosis of cutaneous T-cell lymphoma. Dreno, B., Bureau, B., Stalder, J.F., Litoux, P. Archives of dermatology. (1990) [Pubmed]
  25. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation. Chimenti, S., Cerroni, L., Zenahlik, P., Peris, K., Kerl, H. J. Cutan. Pathol. (1996) [Pubmed]
  26. Mycosis fungoides-like reaction in a patient treated with Gleevec. Clark, S.H., Duvic, M., Prieto, V.G., Prietol, V.G. J. Cutan. Pathol. (2003) [Pubmed]
 
WikiGenes - Universities